Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA3 | P07451 | 4/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA9 | Q16790 | 4/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | TYR | P14679 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9153089 | 0.87 | CA1 (0.36) | CA2CA1HPGDALDH1A1CYP3A4 | |
| SCHEMBL11859127 | 0.84 | CA1 (0.33) | CA2CA1HPGD | |
| Hydroquinone SCHEMBL7915250 | 0.81 | CA1 (0.61) | CA3CA14CA12CA2CA9 | |
| Hydroquinone SCHEMBL9551833 | 0.81 | CA1 (0.61) | CA3CA14CA12CA2CA9 | |
| SCHEMBL10606718 | 0.79 | ESR1 (0.35) | ESR1ESR2 | |
| Hydroquinone SCHEMBL11662646 | 0.75 | MAPT (0.53) | CA3CA14CA12CA2CA9 | |
| SCHEMBL24988670 | 0.74 | — | — | |
| SCHEMBL6515315 | 0.74 | IDO1 (0.35) | — | |
| SCHEMBL5312986 | 0.74 | MAPT (0.44) | CA3CA14CA12CA2CA9 | |
| SCHEMBL6654158 | 0.74 | TPMT (0.40) | CA2CA9CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12623212-B2 | Physically reinforced structured organic film (SOF) anion exchange membranes (AEMs) | XEROX CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| WO-2025121238-A1 | METHOD FOR PRODUCING AROMATIC POLYSULFONE | 住友化学株式会社 | 2025-06-12 | — | — | WO | disclosed |
| US-20250041842-A1 | PHYSICALLY REINFORCED STRUCTURED ORGANIC FILM (SOF) ANION EXCHANGE MEMBRANES (AEMs) | XEROX CORPORATION (US) | 2025-02-06 | — | — | US | disclosed |
| US-20250025843-A1 | FLEXIBLE IONIC BUILDING BLOCKS WITH HIGH IONIC CONDUCTIVITY AND ALKALINE STABILITY FOR USE IN STRUCTURED ORGANIC FILM (SOF) CONTAINING ANION EXCHANGE MEMBRANES (AEMs) | XEROX CORPORATION (US) | 2025-01-23 | — | — | US | disclosed |
| US-20250019506-A1 | FLEXIBLE IONIC STRUCTURED ORGANIC FILM MEMBRANE FORMULATIONS AND METHODS THEREOF | XEROX CORPORATION (US) | 2025-01-16 | — | — | US | disclosed |
| US-20240115975-A1 | CATION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF | XEROX CORPORATION (US) | 2024-04-11 | — | — | US | disclosed |
| EP-4340080-A1 | CATION EXCHANGE MEMBRANES FROM STRUCTURED ORGANIC FILMS AND METHODS THEREOF | Xerox Corporation (US) | 2024-03-20 | — | — | EP | disclosed |
| US-20240018357-A1 | AROMATIC POLYSULFONE, RESIN COMPOSITION, AND METHOD FOR PRODUCING AROMATIC POLYSULFONE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-01-18 | — | — | US | disclosed |
| EP-4269470-A1 | AROMATIC POLYSULFONE, RESIN COMPOSITION, AND METHOD FOR PRODUCING AROMATIC POLYSULFONE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-11-01 | — | — | EP | disclosed |
| CN-116600882-A | Aromatic polysulfone, resin composition, and method for producing aromatic polysulfone | 住友化学株式会社 | 2023-08-15 | — | — | CN | disclosed |
| WO-2008082488-A1 | 4, 5-RING ANNULATED INDOLE DERIVATIVES FOR TREATING OR PREVENTING OF HCV AND RELATED VIRAL INFECTIONS | SCHERING CORPORATION (US) | 2008-07-10 | — | — | WO | disclosed |
| US-7351522-B2 | Concentrated processing composition for silver halide color paper and method of processing | FUJIFILM CORPORATION (JP) | 2008-04-01 | — | — | US | disclosed |
| US-20070269753-A1 | CONCENTRATED PROCESSING COMPOSITION FOR SILVER HALIDE COLOR PAPER AND METHOD OF PROCESSING | FUJIFILM CORPORATION (JP) | 2007-11-22 | — | — | US | disclosed |
| CN-101040219-A | Concentrated composition for silver halide color paper and method of processing | FUJIFILM CORP (JP) | 2007-09-19 | — | — | CN | disclosed |
| US-20070149639-A1 | Polymerizable composition, optical material comprising the composition and method for producing the material | HORIKOSHI HIROSHI | 2007-06-28 | — | — | US | disclosed |
| EP-1780597-A1 | CONCENTRATED COMPOSITION FOR SILVER HALIDE COLOR PAPER AND METHOD OF PROCESSING | FUJIFILM Corporation (JP) | 2007-05-02 | — | — | EP | disclosed |
| EP-1524289-A1 | POLYMERIZABLE COMPOSITION, OPTICAL MATERIAL COMPRISING THE COMPOSITION AND METHOD FOR PRODUCING THE MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2005-04-20 | — | — | EP | disclosed |
| US-20050032646-A1 | Agents for the regulation of gametophytic self-incompatibility and a control method for the breakdown of gametophytic self-incompatibility using the agents | BICBIO CO. LTD. (KR) | 2005-02-10 | — | — | US | disclosed |
| US-20040254258-A1 | Polymerizable composition, optical material comprising the composition and method for producing the material | MITSUBISHI GAS CHEMICAL CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| WO-2004036997-A1 | AGENTS FOR THE REGULATION OF GAMETOPHYTIC SELF-INCOMPATIBILITY AND A CONTROL METHOD FOR THE BREAKDOWN OF GAMETOPHYTIC SELF-INCOMPATIBILITY USING THE AGENTS | BICBIO CO., LTD (KR) | 2004-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12623212-B2 | Physically reinforced structured organic film (SOF) anion exchange membranes (AEMs) | EPCAM, SGMS1, PEF1 | CA3 2056/4885CA14 1074/4885CA12 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.